Peijia Medical (沛嘉医疗) IPO: Hot Deal at Discount
Peijia Medical launched book building to raise up to USD 302 million to list in Hong Kong. It is a leading domestic player in the transcatheter...
439 Views
Peijia Medical (沛嘉医疗) Pre-IPO: Deserves Valuation Premium for the TAVR Late Comer
Peijia Medical is a leading domestic player in the transcatheter valve therapeutic medical device market and the neurointerventional procedural...
411 Views
Peijia Medical IPO Initiation: Let's Have a Heart-To-Heart
Peijia Medical (1740651D CH) is a leading transcatheter heart valve medical device company in China. It has filed for a Hong Kong IPO and is...
342 Views
InnoCare (诺诚健华) IPO Trading: At the Mercy of Retail Flipping
InnoCare, a China-based biotech company founded by a famous scientist, raised USD 270 million at HKD 8.95 per share. In this insight, we will cover...
410 Views
Peijia Medical (沛嘉医疗) Pre-IPO: Reminiscence of Venus Medtech?
Peijia Medical is a leading domestic player in the transcatheter valve therapeutic medical device market and the neurointerventional procedural...
1.2k Views